Author:
Srividya G,Jain M,Mahalakshmi K,Gayathri S,Raman R,Angayarkanni N
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T et al. Meta-Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012; 35 (3): 556–564.
2. Amoaku WM, Saker S, Stewart EA . A review of therapies for diabetic macular oedema and rationale for combination therapy. Eye 2015; 29 (9): 1115–1130.
3. Capitão M, Soares R . Angiogenesis and inflammation crosstalk in diabetic retinopathy. J Cell Biochem 2016; 117 (11): 2443–2453.
4. Kaštelan S, Tomić M, Gverović Antunica A, Salopek Rabatić J, Ljubić S . Inflammation and pharmacological treatment in diabetic retinopathy. Mediators Inflamm 2013; 2013: 213130.
5. Totan Y, Güler E, Gürağaç FB . Dexamethasone intravitreal implant for chronic diabetic macular edema resistant to intravitreal bevacizumab treatment. Curr Eye Res 2016; 41 (1): 107–113.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献